Addressing IUD Efficacy, Eligibility, Myths, and Satisfaction with Adolescents and Young Adults
- 177 Downloads
While IUDs are incredibly safe and highly effective forms of birth control for all individuals, including adolescents and young adults, and have higher continuation rates compared to non-LARC methods, many medical providers still believe that they are inappropriate for use with adolescent and young patients. This lack of knowledge has the potential to negatively impact an adolescent’s or young adult’s reproductive autonomy. In addition, patients and families continue to have concerns around IUD safety based on myths of previous decades and complications from devices no longer available. This chapter will address some of the potential gaps in patient and provider knowledge, including a review of IUD efficacy and eligibility based on resources from the Center for Disease Control and Prevention, a list of resources for evidence-based guidelines, and a discussion of common IUD myths.
KeywordsIUD Adolescent Young adult Efficacy Eligibility Myth Satisfaction Copper IUD Levonorgestrel IUD Safety
American College of Obstetrics and Gynecology
Adolescents and Young Adults
Centers for Disease Control and Prevention
Long-Acting Reversible Contraception
Medical Eligibility Criteria
Pelvic Inflammatory Disease
School-Based Health Center
Selected Practice Recommendations for Contraceptive Use
Sexually Transmitted Infection
- 1.Ott MA, Sucato GS. Committee on adolescence. Contraception for adolescents. Pediatrics. 2014;134:e1257–81.Google Scholar
- 2.Society for Adolescent Health and Medicine, Burke PJ, Coles MS, Di Meglio G, Gibson EJ, Handschin SM, et al. Sexual and reproductive health care: a position paper of the society for adolescent health and medicine. J Adolesc Health. 2014;54:491–6.Google Scholar
- 3.ACOG Committee Opinion No. 735: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2018;131:e130–e139.Google Scholar
- 4.Contraceptive use in the United States. In: Guttmacher Institute [Internet]. Jul 2018 [cited 29 Nov 2018]. Available: https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states.
- 10.Schreiber CA, Barnhart K. In: Strauss JF, Jerome F, Strauss III, Barbieri RL, editors. Yen and Jaffe’s reproductive endocrinology. Philadelphia, PA. Elsevier Health Sciences; 2013.Google Scholar
- 14.Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356:1013–9.Google Scholar
- 15.Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65:1–103.Google Scholar
- 16.CDC – Summary – USMEC – Reproductive Health [Internet]. 28 Sep 2017 [cited 30 Nov 2018]. Available: https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html.
- 17.World Health Organization, Reproductive Health and Research, World Health Organization, World Health Organization, Family and Community Health. Selected practice recommendations for contraceptive use. Geneva: World Health Organization; 2005.Google Scholar
- 18.CDC – Summary – USMEC – Reproductive Health [Internet]. 2 Nov 2018 [cited 6 Jan 2019]. Available: https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html.
- 19.Summary chart of U.S. medical eligibility criteria for contraceptive use. In: CDC [Internet]. [cited 1 Dec 2018]. Available: https://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf.
- 20.CDC – Summary – US SPR – Reproductive Health [Internet]. 27 Sep 2017 [cited 30 Nov 2018]. Available: https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/summary.html.
- 22.Alton TM, Brock GN, Yang D, Wilking DA, Hertweck SP, Loveless MB. Retrospective review of intrauterine device in adolescent and young women. J Pediatr Adolesc Gynecol. 2012;25:195–200.Google Scholar
- 23.Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzmán-Rodríguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001;345:561–7.Google Scholar
- 24.Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years’ comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol. 1991;77:261–4.Google Scholar
- 28.Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75:S16–30.Google Scholar
- 31.Facts are important emergency contraception (EC) and intrauterine devices (IUDs) are not abortifacients. The American College of Obstetricians and Gynecologists [Internet]. Jun 2014 [cited 6 Jan 2019]. Available: www.acog.org/-/media/Departments/Government-Relations-and-Outreach/FactsAreImportantEC.pdf.
- 33.Kavanaugh ML, Frohwirth L, Jerman J, Popkin R, Ethier K. Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives. J Pediatr Adolesc Gynecol. 2013;26:86–95.Google Scholar
- 36.Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16:1277–83.Google Scholar
- 39.Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203:115.e1–7.Google Scholar
- 46.Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015;213:662.e1–8.Google Scholar
- 48.Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;216:364.e1–364.e12.Google Scholar
- 51.Society for Adolescent Health and Medicine. Improving knowledge about, access to, and utilization of long-acting reversible contraception among adolescents and young adults. J Adolesc Health. 2017;60:472–4.Google Scholar